Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma × Quality of Life × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 11 Breast Neoplasms 9 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Gastrointestinal Neoplasms 3 Brain Neoplasms 3 Sarcoma 2 Pain 2 Oligodendroglioma 2 Multiple Myeloma 2 Lung Neoplasms 2 Hematologic Neoplasms 2 Glioma 2 Glioblastoma 2 Fatigue 2 Esophageal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Ascites 2 Weight Loss 1 Uterine Cervical Neoplasms 1 To Observe Whether the Fucoidan Can Improve the Quality of Life of the Such Patients Receiving the Neoadjuvant CCRT 1 Thrombocytopenia 1 Symptom Management 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Splenomegaly 1 Speech 1 Sexual Dysfunction, Physiological 1 Sex Cord-Gonadal Stromal Tumors 1

Interventions

Cyclophosphamide 382 Rituximab 332 Etoposide 191 Vincristine 176 Filgrastim 173 Doxorubicin 170 Prednisone 143 Radiotherapy 136 Cytarabine 134 fludarabine phosphate 121 Melphalan 111 Methotrexate 110 Peripheral Blood Stem Cell Transplantation 107 fludarabine 102 Busulfan 86 Dexamethasone 74 Carmustine 64 Granulocyte Colony-Stimulating Factor 61 Tacrolimus 59 Whole-Body Irradiation 56 Mycophenolic Acid 56 Gemcitabine 56 Bendamustine Hydrochloride 56 Antilymphocyte Serum 55 Lenalidomide 52 Cyclosporine 51 Ifosfamide 50 Bortezomib 49 Methylprednisolone 42 Leucovorin 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04187118 2023-09-21

QUALIPSO-L

University Hospital, Toulouse

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡